Matthew M. Riggs, Ph.D.

Chief Science Officer

Matt offers over 16 years of industry experience including the application of modeling and simulation for clinical pharmacology and later phase drug development decisions. Matt’s interests include the development and application of mechanistic exposure-response and systems pharmacology models to quantitatively integrate physiology, pharmacology, senescence and disease understandings; this to guide translational and clinical research toward improved preventative and interventional therapeutics.

Recent publications by this scientist

Pharmacometrics and QSP: Convergence, Commonalities, and Continuities

March 31, 2022

Matthew Riggs. Presented at the third World Conference on Pharmacometrics (WCoP) virtual hybrid meeting. 31 March 2022, South Africa and online. See video here for the first half of this presentation covering “Compare and Contrast” presented by Stacey Tannenbaum, Ph.D.

WCoP2022-Riggs-CompareCollide

Download PDF

A model-based analysis to guide gonadotropin-releasing hormone receptor antagonist use for management of endometriosis

February 4, 2022

Pohl OBaron KRiggs MFrench JGarcia RGotteland JPBr J Clin Pharmacol20211– 13. doi:10.1111/bcp.15171

View More